Condition
Neurodevelopmental Outcomes
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 2 (1)
Trial Status
Completed2
Recruiting2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07203469Not ApplicableRecruitingPrimary
Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth
NCT05849077Not ApplicableRecruiting
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
NCT02528227Not ApplicableCompleted
NICU Parent Education Program
NCT03867669Not ApplicableUnknownPrimary
Single Patient Room Versus Open Bay in NICU
NCT00589953Phase 2Terminated
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00975949CompletedPrimary
Neurodevelopmental Outcomes and Fluconazole Prophylaxis
Showing all 6 trials